1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
APOE in the bullseye of neurodegenerative diseases : impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
(
- Contribution to journal › Scientific review
-
Mark
Brain integrity is altered by hepatic APOE ε4 in humanized-liver mice
(
- Contribution to journal › Article
- 2019
-
Mark
α-synuclein in the pathophysiology of Alzheimer's disease
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Amyloid-beta 1-40 is associated with alterations in NG2+ pericyte population ex vivo and in vitro
(
- Contribution to journal › Article
-
Mark
Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease
(
- Contribution to journal › Article